Regulation of adenylate cyclase activity in hamster adipocytes

[1]  G. Schultz,et al.  Different inhibitory effect of adrenaline on platelet adenylate cyclase in the presence of GTP plus cholera toxin and of stable GTP analogues , 1979, Naunyn-Schmiedeberg's Archives of Pharmacology.

[2]  G. Schultz,et al.  GTP-dependent inhibition of cardiac adenylate cyclase by muscarinic cholinergic agonists , 1979, Naunyn-Schmiedeberg's Archives of Pharmacology.

[3]  J. Fain,et al.  Effect of NAD, nicotinamide and nicotinic acid on cyclic AMP accumulation by fat cells , 1979, Naunyn-Schmiedeberg's Archives of Pharmacology.

[4]  K. Jakobs,et al.  Agonistic and antagonistic effects of various α-adrenergic agonists in human platelets , 1979, Naunyn-Schmiedeberg's Archives of Pharmacology.

[5]  P. Presek,et al.  Alpha noradrenergic receptors in brain membranes: Sodium, magnesium and guanyl nucleotides modulate agonist binding , 2004, Naunyn-Schmiedeberg's Archives of Pharmacology.

[6]  James H. Clark,et al.  AGONISTIC AND ANTAGONISTIC PROPERTIES OF CLOMIPHENE , 1982 .

[7]  K. Jakobs.  Inhibition of adenylate cyclase by hormones and neurotransmitters , 1979, Molecular and Cellular Endocrinology.

[8]  G. Schultz,et al.  Inhibition of hamster fat cell adenylate cyclase by prostaglandin E1 and epinephrine: Requirement for GTP and sodium ions , 1979, FEBS letters.

[9]  A. Blume,et al.  A physiological requirement of Na+ for the regulation of cAMP levels in intact NG108-15 cells. , 1979, Life sciences.

[10]  R. Lefkowitz,et al.  Agonist-specific effects of guanine nucleotides on alpha-adrenergic receptors in human platelets. , 1979, Molecular pharmacology.

[11]  T. Walseth,et al.  The enzymatic preparation of [α-32P]nucleoside triphosphates, cyclic [32P]AMP, and cyclic [32P]GMP☆ , 1979 .

[12]  M. Nirenberg,et al.  Regulation of adenylate cyclase of neuroblastoma x glioma hybrid cells by alpha-adrenergic receptors. I. Inhibition of adenylate cyclase mediated by alpha receptors. , 1979, The Journal of biological chemistry.

[13]  Y. Giudicelli,et al.  Direct biochemical evidence for the existence of α‐adrenergic receptors in hamster white adipocyte membranes , 1979, FEBS letters.

[14]  K. Jakobs.  Inhibition of adenylate cyclase by hormones and neurotransmitters. , 1979, Molecular and cellular endocrinology.

[15]  H. Kather,et al.  Antagonistic effects of prostaglandin E1 and nicotinic acid on the human fat cell adenylate cyclase. , 1979, Research communications in chemical pathology and pharmacology.

[16]  R. Schimmel.  Inhibition of lipolysis in hamster epididymal adipocytes by selective alpha-adrenergic agents. Evidence for cyclic AMP-dependent and independent mechanisms. , 1979, Biochimica et biophysica acta.

[17]  D. Cooper,et al.  Adenosine analogs inhibit adipocyte adenylate cyclase by a GTP-dependent process: basis for actions of adenosine and methylxanthines on cyclic AMP production and lipolysis. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[18]  J. W. Fleming,et al.  Muscarinic cholinergic receptor modulation of beta-adrenergic receptor affinity for catecholamines. , 1978, The Journal of biological chemistry.

[19]  R. Lefkowitz,et al.  Agonist-specific effects of monovalent and divalent cations on adenylate cyclase-coupled alpha adrenergic receptors in rabbit platelets. , 1978, Molecular pharmacology.

[20]  S. Snyder,et al.  Guanyl nucleotide influences on 3H-ligand binding to alpha-noradrenergic receptors in calf brain membranes. , 1978, The Journal of biological chemistry.

[21]  A. Blume.  Interaction of ligands with the opiate receptors of brain membranes: regulation by ions and nucleotides. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[22]  M. Nirenberg,et al.  Regulation of adenylate cyclase activity mediated by muscarinic acetylcholine receptors. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[23]  G. Schultz,et al.  Inhibition of platelet adenylate cyclase by epinephrine requires GTP , 1978, FEBS letters.

[24]  M. Nirenberg,et al.  Opiate-dependent modulation of adenylate cyclase. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[25]  G. Schultz,et al.  Reduction of adenylate cyclase activity in lysates of human platelets by the alpha-adrenergic component of epinephrine. , 1976, Journal of cyclic nucleotide research.

[26]  Burns Tw,et al.  The effect of alpha and beta adrenergic receptor stimulation on the adenylate cyclase activity of human adipocytes. , 1975 .

[27]  S. Snyder,et al.  Opiate Receptor Binding of Agonists and Antagonists Affected Differentially by Sodium , 1974 .

[28]  R. Butcher,et al.  Effects of antilipolytic agents and alpha-adrenergic antagonists on cyclic AMP metabolism in hamster white adipocytes. , 1973, Biochimica et biophysica acta.

[29]  R. Butcher,et al.  Control of cyclic AMP levels in isolated fat cells from hamsters. , 1973, Biochimica et biophysica acta.

[30]  J. Fain.  Biochemical aspects of drug and hormone action on adipose tissue. , 1973, Pharmacological reviews.

[31]  Burns Tw,et al.  Studies on the role of cyclic AMP in human lipolysis. , 1972 .

[32]  G. Robison,et al.  Studies on the role of cyclic AMP in human lipolysis. , 1972, Advances in cyclic nucleotide research.

[33]  E. G. Loten,et al.  An effect of insulin on adipose-tissue adenosine 3':5'-cyclic monophosphate phosphodiesterase. , 1970, The Biochemical journal.

[34]  Butcher,et al.  Effects of lipolytic and antilipolytic substances on adenosine 3',5'-monophosphate levels in isolated fat cells. , 1968, The Journal of biological chemistry.

[35]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.